Illumina Inc (NASDAQ: ILMN) kicked off on Tuesday, down -0.79% from the previous trading day, before settling in for the closing price of $145.21. Over the past 52 weeks, ILMN has traded in a range of $86.49-$151.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 7.40%. While this was happening, its average annual earnings per share was recorded 367.64%. With a float of $158.48 million, this company’s outstanding shares have now reached $159.00 million.
The extent of productivity of a business whose workforce counts for 12010 workers is very important to gauge. In terms of profitability, gross margin is 62.02%, operating margin of -8.72%, and the pretax margin is -68.53%.
Illumina Inc (ILMN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Illumina Inc is 0.52%, while institutional ownership is 89.41%. The most recent insider transaction that took place on Oct 14 ’24, was worth 720,132. Before that another transaction happened on Aug 15 ’24, when Company’s Officer proposed sale 3,956 for $122.28, making the entire transaction worth $483,740.
Illumina Inc (ILMN) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported 0.33 earnings per share (EPS), higher than consensus estimate (set at 0.12) by 0.21. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.94 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 367.64% per share during the next fiscal year.
Illumina Inc (NASDAQ: ILMN) Trading Performance Indicators
Take a look at Illumina Inc’s (ILMN) current performance indicators. Last quarter, stock had a quick ratio of 0.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.18. Likewise, its price to free cash flow for the trailing twelve months is 64.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -19.17, a number that is poised to hit 0.88 in the next quarter and is forecasted to reach 4.41 in one year’s time.
Technical Analysis of Illumina Inc (ILMN)
The latest stats from [Illumina Inc, ILMN] show that its last 5-days average volume of 1.43 million was inferior to 2.02 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 59.88%. Additionally, its Average True Range was 4.77.
During the past 100 days, Illumina Inc’s (ILMN) raw stochastic average was set at 85.51%, which indicates a significant increase from 57.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.75% in the past 14 days, which was lower than the 39.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $133.40, while its 200-day Moving Average is $126.49. Now, the first resistance to watch is $144.92. This is followed by the second major resistance level at $145.78. The third major resistance level sits at $147.09. If the price goes on to break the first support level at $142.75, it is likely to go to the next support level at $141.44. Assuming the price breaks the second support level, the third support level stands at $140.58.
Illumina Inc (NASDAQ: ILMN) Key Stats
The company with the Market Capitalisation of 22.95 billion has total of 159,300K Shares Outstanding. Its annual sales at the moment are 4,504 M in contrast with the sum of -1,161 M annual income. Company’s last quarter sales were recorded 1,112 M and last quarter income was -1,988 M.
